WOOJUNG BIO Adjusts Conversion Price Upward, Reducing Potential Dilution and Benefiting Existing Shareholders
The conversion price of the 8th convertible bond was adjusted upward from 2,515 KRW to 2,764 KRW due to the contractual refixing condition triggered by the rise in market price. This adjustment was made automatically without a board resolution.
As a result, the number of convertible shares decreased from 1,391,650 to 1,266,280, a reduction of approximately 125,370 shares or about 0.74% of total outstanding shares. This reduces potential dilution and positively impacts existing shareholder value.
WOOJUNG BIO's market capitalization is approximately 414.8 billion KRW with a current stock price of 2,465 KRW. This conversion price adjustment is a routine disclosure driven by stock price appreciation and has no connection with the company's financial soundness or capital raising activities.
[AI Summary]The upward adjustment of the conversion price reduces potential dilution due to rising stock prices, benefiting existing shareholders. However, it does not signify any major managerial changes and may act as a mildly positive signal for short-term stock performance.